DAFTAR PUSTAKA
Abdurrahman, F., Suryanti, S., Sihombing, A. 2018. Hubungan Body Mass Index (BMI) dengan Gleason Score pada Penderita Keganasan Prostat di Rumah Sakit Umum Hasan Sadikin. Journal of Medicine and Health. 2(2): 780-787.
American Cancer Society. 2021. Key Statistics for Prostate Cancer. Atlanta, American Cancer Society.
Aminudin, M., Sari, R., Djausal, A. 2022. Aspek Makronutrien Dalam Perkembangan Penyakit Kanker Prostat. Medula. 12(3): 531-536.
Ao, M., Williams, K., Bhowmick, A., Hayward, W. 2006. Transforming Growth Factor-Beta Promotes Invasion in Tumorigenic But Not in Nontumorigenic Human Prostatic Epithelial Cells. Cancer Research. 66(16): 8007-8016.
Ati, V., Rahmadianto, H., Munfiah, S. Faktor-faktor Risiko yang Berhubungan dengan Kejadian Kanker Prostat (Studi Kasus di RSUD Prof. Dr. Margono Soekarjo Purwokerto). Mandala of Health. 14(2): 67-73.
Bai, P., Hu, M., Xu, H., Zhu, W., Hu, J., Yang, T., et al. 2015. Body Mass Index is Associated with Higher Gleason Score and Biochemical Recurrence Risk Following Radical Prostatectomy in Chinese Men: A Retrospective Cohort Study and Meta-Analysis. World Journal of Surgical Oncology. 13(311): 1-8.
Balatif, R. Sukma, A. 2021. Memahami Kaitan Gaya Hidup dengan Kanker: Sebagai Langkah Awal Pencegahan Kanker. SCRIPTA SCORE. 3(1): 40-50.
Bayu, P., Hadibrata, E., Triyandi, R., Hanriko, R. 2021. Hubungan Kadar Prostate Specific Antigen (PSA) dengan Derajat Histopatologi Kanker Prostat di RSUD Dr. H. Abdoel Moloek Provinsi Lampung Periode 2019-2020. Journal Agromedicine. 8(1): 1-9.
Brattain, M., Markowitz, S., Willson, J. 1996. The Type II Transforming Growth Factor-Beta Receptor As A Tumor-Suppressor Gene. Current Opinion in Oncology. 8(1): 49-53.
Budirejeki, M., Sugiritama, I. 2013. Peranan Lycopene Dalam Pencegahan Kanker Prostat. Jurnal Media Udayana. 2(11): 1-19.
Chaudhury, A., Howe, P. 2009. The Tale of Transforming Growth Factor- (TGF-) Signaling: A Soigné Enigma. IUBMB Life. 61(10) : 929-939.
Chen, N., Zhou, Q. 2016. The Evolving Gleason Grading System. Chinese Journal of Cancer Research. 28(1) : 58-64.
Chung, B., Horie, S., Chiong, E. 2019. The incidence, mortality, and risk factors of prostate cancer in Asien men. Prostate International. 7(1) : 1-8.
Clark, D., Coker, R. 1998. Transforming Growth Factor-Beta (TGF-). The International Journal of Biochemistry & Cell Biology. 30(3) : 293-298.
Dahlan, M. 2010. Besar Sampel dan Cara Pengambilan Sampel Dalam Penelitian Kedokteran dan Kesehatan. Jakarta, Salemba Medika.
Epstein, I., Egevad, L., Amin, B., Delahunt, B., Srigley, J., Humphrey, P. 2016. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 40(1) : 244–252.
Fabregat, I., Caceres, J., Sanchez, A., Dooley, S., Dewidar, B., Giannelli, G. et al. 2016.
TGF- Signaling and Liver Disease. The Federation of European Biochemical Societies. 283(12): 2219-2232.
Ferry, S., Umbas, R., Danarto, Hakim, L., Warli, S., Hamid, A. et al. 2022. Panduan Penanganan Kanker Prostat. Jakarta, Ikatan Ahli Urologi Indonesia.
Frick, J., Aulitzky, W. 1991. Physiology of the prostate. Infection. 19(3) : 115-118.
Fujita, K., Nonomura, N. 2018. Urinary biomarkers of prostate cancer. International Journal of Urology. 25(9) : 770-779.
Galluzzi, C. 2018. Prostate Cancer: Diagnostic Criteria and Role of Immunohistochemistry. Modern Pathology. 31(1):12-21.
Gann, P. 2002. Risk Factors for Prostate Cancer. Reviews in Urology. 4(5) : 3-10.
Gioia, A., Manco, R., Tenaglia, R., Tirabassi, G., Balercia, G. 2014. Relationship Between BMI, PSA, and Histopathological Tumor Grade in A Caucasian Population Affected by Prostate Cancer. Global Journal of Medical and Clinical Case Report. 1(2): 37-42.
Gupta, N., McVary, K. 2017. Physiological and Pharmacological Studies of The Prostate Gland. The Journal of Urology. 197(1): 26-27.
Harahap, S. 2018. Gambaran Kejadian Kanker Prostat Pada Penderita Diabetes Mellitus di RSUP H. Adam Malik Medan. Jurnal Penelitian Keperawatan Medik. 1(1): 52-56.
Hardini, N., Citrawari, M. 2021. Korelasi Skor Gleason dengan Kadar Prostat Spesifik Antigen (PSA) Pada Pasien Karsinoma Prostat. Majalah Kedokteran Andalas.
44(2): 71-79.
Henry, G., Malewska, A., Joseph, D., Malladi, V., Lee, J., Torrealba, J. et al. 2018. A Cellular Anatomy of The Normal Adult Human Prsotate and Prostatic Urethra. Cell Press. 25(12): 3530-3542.
Hidayat, S. 2021. Prevalensi Adenokarsinoma Prostat Berdasarkan Usia dan Gleason Score di Bagian/SMF Patologi Anatomi RSUD Prof. Dr. Margono Soekarjo Purwokerto Periode 2016-2020. Skripsi. Fakultas Kedokteran. Universitas Jenderal Soedirman, Purwokerto. (Tidak dipublikasikan)
Hilimi, N., Komarudin, U., Utomo, T. 2019. Prevalence of Prostate Cancer in People with Prostate Disease in Al-Ihsan Regional General Hospital Jawa Barat Province in 2013-2018. Prosiding Pendidikan Dokter. 5(1) : 883-891.
Hu, S., Yu, W., Lv, T., Chang, S., Li, X., Jin. J. 2014. Evidence of TGF-β1 Mediated Epithelial-mesenchymal Transition in Immortalized Benign Prostatic Hyperplasia Cells. Molecular Membrane Biology. 31(2-3): 103-110.
Humphrey, P. 2017. Histopathology of Prostat Cancer. Cold Spring Harbor Perspectives in Medicine. 7(10) : 1-21.
Hoadley, K., Yau, C., Hinoue, T., Wolf, D., Lazar, A., Drill, E. et al. 2018. Cell-of- Origin Patterns Dominate The Molecular Classification of 10.000 Tumors from 33 Types of Cancer. Cell. 173(2) : 291-304.
Homalessy, V., Christina, S., Sumbayak, E. 2022. Hubungan Indeks Massa Tubuh dengan Kejadian Kanker Prostat dan Gleason Score di Rumah Sakit Siloam Kupang. Jurnal MedScientiae. 1(1): 97-101.
Hyuna, S., Ferlay, J., Siegel, R., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F. 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. A Cancer Journal for Clinicians. 71(1): 209-249.
Ittmann, M. 2018. Anatomy and Histology of the Human and Murine Prostate. Cold Spring Harbor Perspectives in Medicine. 8(5) : 1-6.
Jung, C., Iyengar, S., Blahnik, K., Jiang, J., Tahimic, C., Torok, N., et al. 2012. Human ESC Self-renewal Promoting MicroRNAs Induce Epithelial-Mesenchymal Transition in Hepatocytes by Controlling The PTEN and TGF- Tumor Supressor Signaling Pathways. Molecular Cancer Research. 10(7): 979-991.
Kakehi, Y., Oka, H., Mitsumori, K., Itoh, N., Ogawa, O., Yoshida, O. 1996. Elevation of Serum Transforming Growth Factor-P I Level in Patients with Metastatic Prostate Cancer. Urology Oncology. 2(1) : 131-135.
Larissa, U., Hanriko, R., Perdani, R. 2019. Hubungan Usia dan Indeks Massa Tubuh terhadap Derajat Histopatologi Kanker Prsotat di RSUD Dr. H. Abdul Moeloek Bandar Lampung Periode 2017. Medula. 9(1): 15-19.
Lawrence, D. 1996. Transforming Growth Factor-Beta: A General Review. Eur Cytokine Netw. 7(3) : 363-374.
Lawrenti, H. 2019. Perkembangan Terapi Kanker Prostat. Continuing Medical Education. 46(8) : 521-528.
Lee, H., Akin-Olugbade, O., Kirschenbaum, A. 2011. Overview of Prostate Anatomy, Histology, and Pathology. Endocrinology and Metabolism Clinics of North America. 40(3) : 565-575.
Lenaini, I. 2021. Teknik Pengambilan Sampel Purposive dan Snowball Sampling.
HISTORIS: Jurnal Kajian, Penelitian & Pengembangan Pendidikan Sejarah.
6(1) : 33-39.
Munjal, A. Leslie, S. 2022. Gleason Score. StatPearls Publishing [Internet].
Murray, T. 2021. Prostate Cancer. Brisbane, Exon Publications.
Paner, G. 2010. Prostate gland and seminal vesicle. Diagnostic pathology:
Genitourinary. 3(1) : 4–156.
Pepe, P., Pennisi, M. 2015. Gleason Score Stratification According to Age at Diagnosis in 1028 Men. Contemporary Oncology. 19(6): 471-473.
Pract, B. 2006. Clinical Features of Prostate Cancer Before Diagnosis: A Population- based, Case-control Study. British Journal of General Practice. 56(531) : 756- 762.
Pratiwi, N., Riastiti, Y., Irawiraman, H., Danial. 2023. Hubungan Usia dan Kadar Prostate Specific Antigen (PSA) dengan Derajat Histopatologi
Adenokarsinoma Prostat di RSUD Abdoel Wahab Sjahranie Samarinda.
Jurnal Kesehatan Andalas. 12(2): 64-69.
Pu, H., Collazo, J., Jones, E., Gayheart, D., Sakamoto, S., Vogt, A., et al. 2009.
Dysfunctional Transforming Growth Factor-β Receptor II Accelerated Prostate Tumorigenesis in The TRAMP Mouse Model. Cancer Research.
69(18): 7366-7374.
Putriyuni, A. Hilbertina, N. 2014. Adenokarsinoma Prostat: Penilaian Prognostik dan Derajat Histopatologi. Majalah Kedokteran Andalas. 37(2): 93-100.
Rebello, R., Oing, C., Knudsen, K., Loeb, S., Johnson, D., Reiter, R., Gillessen, S., Kwast, T., Bristow, R. 2021. Prostate Cancer. Nature Reviews. 7(9) : 1-27.
Reis, S., Junior, J., Antunes, A., Canavez, J., Abe, D., Cruz, J., Oglio, M., Crippa, A., Passerotti, C., Filho, L., Viana, N., Srougi, M., Leite, K. 2011. TGF-β1 expression as a biomarker of poor prognosis in prostate cancer. CLINICS.
66(7) : 1143-1147.
Saini, S. 2016. PSA and beyond: alternative prostate cancer biomarkers. International Society for Cellular Oncology. 39(2) : 97-106.
Sanni. 2017. Hubungan Kadar Prostate Specific Antigen dengan Gleason Score pada Penderita Adenokarsinoma Prostat di RSUP H. Adam Malik. Repositori Institusi Universitas Sumatera Utara. 30(3): 181-184.
Sari, Y. Duarsa, G., Mahadewa, T. 2019. Faktor Risiko yang Mempengaruhi Pembesaran Volume Prostat Pada Pasien Pembesaran Prostat Jinak yang Dilakukan Reseksi Prostat Transuretra. Medicina. 50(2): 3390-334.
Sastroasmoro, S. 2014. Dasar-dasar Metodologi Penelitian Klinis. Jakarta, Sagung Seto.
Sharifi, N., Hurt, M. Kawasaki, T., Farrar, L. 2007. TGFBR3 Loss and Consequences in Prostate Cancer. Prostate. 67(3): 301-311.
Singh, P., Dogra, P., Gupta, N., Nayyar, R., Seth, A., Javali, T. et al. 2011. Correlation Between The Preoperative Serum Prostate Specific Antigen, Gleason Score, and Clinical Staging With Pathological Outcome Following Robot-Assisted Radical Prostatectomy: An Indian Experience. Indian Journal of Cancer.
48(4): 483-487.
Singh, O., Bolla, R. 2022. Anatomy, Abdomen and Pelvis, Prostate. StatPearls Publishing [Internet].
Soebhali, B., Soetojo, Soebadi, D., Hendromartono, Widodo, J. 2009. Hubungan TGF-
1 dan Estrogen dengan Volume Prostat Pada Pasien BPH, Pasien Tua Non BPH, dan Pasien Muda. Jurnal Riset Indragiri. 16(1): 6-10.
Solang, V., Monoarfa, A., Tjandra, F. 2016. Profil Penderita Kanker Prostat di RSUP Prof. Dr. R. D. Kandou Manado Periode Tahun 2013-2015. Jurnal e-Clinic.
4(2): 1-8.
Stephenson, A., Klein, E. 2016. Epidemiology, etiology, and prevention of prostat cancer. Philedelphia, Elsevier.
Tanto, C., Liwang, F., Hanifati, S., Pradipta, E. 2014. Kapita Selekta Kedokteran Edisi Ke-14. Jakarta, Media Aesculapius FK UI.
Torrealba, N., Vera, R., Fraile, B., Onsurbe, P., Paniagua, R., Royuela, M. 2019. TGF- β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer. Aging Male. 23(5) : 801-811.
Turley, S., Finger, C., Hempel, N., How, T., Fields, A., Blobe, C. 2007. The Type III Transforming Growth Factor-Beta Receptor As A Novel Tumor Supressor Gene in Prostate Cancer. Cancer Research. 67(3): 1090-1098.
Wikstrom, P., Damber, J., Bergh, A. 2001. Role of Transforming Growth Factor-1 in Prostate Cancer. Microscopy Research and Technique. 52(1): 411-419.
World Cancer Research Fund International. 2022. Prostate cancer statistics. World Cancer Research Fund International, London.
Wulandari, E. Hapsari R. 2017. Efek Ekstrak Biji Jarak Pagar (Jatropha curcas L) Terhadap Regulasi Ekspresi Gen TGF-β1 Sebagai Marker Tumor. Traditional Medicine Journal. 22(1):25-30.
Yumoto, K., Eber, M., Wang, J., Cackowski, F., Decker, A., Lee, E., et al. 2016. Axl is Required for TGF-β2-induced Dormancy of Prostate Cancer Cells in The Bone Marrow. Scientific Reports. 6(1): 1-16.
Zhifang, M., Jianming, W., Lingyan, D., Yujun, C. 2020. Identification of Novel Biomarkers Correlated with Prostate Cancer Progression by An Integrated Bioinformatic Analysis. Medicine. 99(28) : 1-10.
